Mendez Celeste S MD Phoenix, AZ - 85014

Mendez Celeste S MD is categorized under Family Planning and Birth Control Clinics in Phoenix, AZ .

Mendez Celeste S MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Planning and Birth Control Clinics business, which does work in the B2C market, and is classified as a Family Planning and Birth Control Clinics, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Celeste Mendez at the company’s single location by writing to 5651b North 7th St, Phoenix, Arizona AZ 85014 or by phoning (602) 268-1588. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mendez Celeste S MD
Contact Person: Celeste Mendez
Address: 5651b North 7th St, Phoenix, Arizona 85014
Phone Number: (602) 268-1588
Website Address: plannedparenthood.org
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Planning and Birth Control Clinics
SIC Code: 8093
NAICS Code: 6211110
Share This Business:

Mendez Celeste S MD was started in 0 to provide professional Family Planning and Birth Control Clinics under the SIC code 8093 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Celeste Mendez for inquiries that concern Mendez Celeste S MD by calling the company number (602) 268-1588, as your correspondence is most welcome. Additionally, the physical location of the single location of Mendez Celeste S MD can be found at the coordinates 33.50406,-112.08264 as well as the street address 5651b North 7th St in Phoenix, Arizona 85014.

For its online presence, you may visit Mendez Celeste S MD’s website at plannedparenthood.org and engage with its social media outlets through on Twitter and on Facebook.